Background: Among potentially malignant disorders, oral leukoplakia is the most common in clinical practice. The aim of this study was to assess risk factors associated with oral leukoplakia. Methods: This retrospective study included 142 patients diagnosed with oral leukoplakia according to World Health Organization clinical and histopathological criteria and a control group of healthy subjects matched for age and gender. Sociodemographic data were registered for each patient: age, gender, smoking and alcohol consumption. Leukoplakia characteristics were also registered: size, position, clinical form, and presence or absence of dysplasia; all cases of leukoplakia were classified systematically according to clinicopathological stage. Blood lipid component levels of total cholesterol, high-density lipoproteins, low-density lipoproteins and triglycerides were compared between groups. Results: Smoking had a significant effect on the risk of leukoplakia (P = 0.01, odds ratio (OR) = 8.33). High glucose levels also increased the probability of leukoplakia (P = 0.03, OR = 6.35), as did low-density lipoproteins (P = 0.049, OR = 5.65). The risk of dysplasia increased among patients presenting the non-homogeneous form of leukoplakia (P = 0.039, OR = 9.06) and among smokers (P = 0.044, OR = 28.33). Conclusions: Smoking, increased glucose and low-density lipoproteins in the blood are associated with a risk of oral leukoplakia.
INTRODUCTION
Oral cancer is the most frequently occurring neoplasia of the head and neck, with a worldwide incidence of over 300 000 cases annually. This neoplasia has high morbidity and mortality, with a survival rate of less than 50% within 5 years. 1, 2 Approaches to effective management include early detection of any potentially malignant oral disorders, of which oral leukoplakia (OL) is the most common with a prevalence of 2.60% (95% confidence interval (CI) = 1.72-2.74). 3 In recent years, numerous epidemiological studies have investigated environmental risk factors for oral cancer and precancer that include smoking, alcohol consumption, betel-quid chewing and some types of viral infections. 1, [4] [5] [6] [7] [8] [9] [10] The malignant transformation of OL and risk assessment present major challenges to the medical profession as the progression, stability and/or regression of a lesion is difficult to predict and to explain. [8] [9] [10] [11] Given this scenario, the possibility identifying those OL patients with a higher risk of developing cancer is fundamental for better management of the disorder. 7, 8 For this reason, the prognostic factors of OL have been subject to much discussion but nevertheless remain controversial. In spite of major advances in molecular biochemistry, to date no single marker or set of markers have been established that can reliably predict the malignant transformation of OL. [4] [5] [6] Recent biochemical research aimed at cancer risk assessment has shown that lipids alter quantitatively during carcinogenesis and are associated with various types of cancer including oral cancer and potentially malignant oral disorders, so that these could serve as an early marker of neoplastic changes. [12] [13] [14] [15] [16] [17] [18] [19] [20] The objective of this study was to assess the association of various risk factors in a cohort of patients with OL compared with healthy controls, including 
Australian Dental Journal
The official journal of the Australian Dental Association blood glucose, cholesterol, triglycerides and lipoprotein levels.
METHODS

Patients
This retrospective study included 142 consecutive patients attending the Oral Medicine Teaching Unit at the University of Murcia (Spain) over a 10-year period (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) . The study protocol was approved by the University of Murcia Research and Ethics Committee.
Inclusion criteria were men and women over the age of 18 years with OL diagnosed according to the clinical and histopathological diagnostic criteria proposed by the World Health Organization (WHO), 21 and who were willing to give their informed consent to take part.
Exclusion criteria were: subjects receiving drug treatment (including specific treatments such as systemic corticosteroids, retinoid acid or immunosuppressants).
The control group was made up of 67 healthy subjects of the same socioeconomic characteristics who were not taking any medication (systemic corticosteroids, retinoid acid or immunosuppressants) and had no lesions or inflammatory processes in their oral cavities (oral lichen planus, aphthous ulcers, Sj€ ogren's syndrome, fibroma, mucocele, reactive lesions, atrophic glossitis, impacted molar extractions), consecutively admitted to the outpatient clinic in oral medicine.
A clinical history was made for each subject registering age, gender, smoking (yes/no), alcohol consumption (yes/no), and in the case of study group subjects, patients' leukoplakia characteristics: size, position, clinical form and presence or absence of dysplasia (none, mild, moderate or severe). All cases of leukoplakia were also classified systematically according to clinicopathological stage. 6 Blood evaluations were performed for 65 leukoplakia patients (biochemical data were complete) and 68 control subjects registering the following parameters: glucose, more than 100 mg/dL; triglycerides, more than 150 mg/dL; total cholesterol, more than 200 mg/dL; low-density lipoprotein (LDL) cholesterol, more than 130 mg/dL; high-density lipoprotein (HDL) cholesterol, less than 40 mg/dL (based on the National Cholesterol Education Program Adult Treatment Plan III definitions); 22 and Castelli's risk index (total cholesterol / HDL cholesterol), more than 5.1 for men or more than 4.5 for women (identification of at risk individuals for cardiovascular disease).
Statistical analysis
Statistical analysis was performed using SPSS version 22.0 statistical software (SPSS, Chicago, IL, USA). Basic descriptive data were calculated so that for qualitative variables the number of cases in each category produced a corresponding percentage and for each quantitative variables, a maximum, minimum, mean and standard deviation were obtained. Pearson's chisquared test was used to compare demographic variables (gender and age, smoking and alcohol consumption) between the study and control groups. Student's t-test was used to compare the two groups, checking distribution with the Kolmogorov-Smirnov test. Logistic regression analysis was used to evaluate the contribution of sociodemographic and laboratory variables to risk of leukoplakia and risk of dysplasia. The Hosmer-Lemeshow test was applied to evaluate model fit, and classification of the model obtained in relation to individual subjects (compared with general observations). Statistically significant difference was set at P < 0.05.
RESULTS
The study sample of patients with leukoplakia consisted of 142 subjects of whom 52.1% (74 patients) were aged under 55 years and 47.9% (68 patients) were aged over 55 years. The average age at which leukoplakia appeared was 53.5 AE 12.2 years. As for gender, 44.4% of patients with leukoplakia were female and 55.6% male. (Table 1 ). The average age of the control group was 51.2 AE 8.2 years.
Leukoplakia lesions can be single or multiple; the most common manifestations in the present sample were single (76.1%). The most frequently observed site of leukoplakia was the gums (43%), followed by the buccal mucosa (19.7%). The most usual size was less than 2 cm (58.5%), and the most frequently occurring clinical form was homogeneous (83.8%) ( Table 2 ). According to OL classification, 6 most cases were phase I (40.1%), followed by phase III (24.7%), phase II (22.5%) and phase IV (12.7%). Most patients (N = 93) did not present dysplasia (65.5%). Biochemical blood analysis evaluated glucose, cholesterol, triglycerides, HDL and LDL, comparing the study and control groups (Table 3) . Table 4 shows the results of logistic regression analysis used to evaluate the contribution of sociodemographic variables to the risk of leukoplakia (gender, age, smoking, alcohol consumption) and laboratory variables (atherogenic index, glucose, triglycerides, HDL and LDL).
It can be seen that smoking shows a significant effect on the risk of leukoplakia, so that smoking increases risk (P = 0.01, odds ratio (OR) = 8.33). High glucose (>100 mg/dL) or LDL levels (>130 mg/ mL) also increased the probability of leukoplakia: glucose (P = 0.03, OR = 6.35); LDL (P = 0.049, OR = 5.65). In model fit evaluation, significance testing confirmed statistical significance and that the logistic regression was model valid.
The factors associated with leukoplakias with dysplasia (Table 5) , logistic regression analysis of the sociodemographic variables (age, gender, alcohol consumption and smoking), clinical variables (form, size and localization of the leukoplakia) and laboratory variables (atherogenic index, glucose, triglycerides, HDL and LDL) showed that smoking had a significant effect on the risk of dysplasia (P = 0.044, OR = 28.33). The nonhomogeneous clinical form presented a significant effect, increasing the probability of dysplasia (P = 0.039, OR = 9.06). In model evaluation, significance testing confirmed statistical significance and that the logistic regression was model valid. The Hosmer-Lemeshow test showed that model fit was adequate (P = 0.591).
DISCUSSION
The results of the present study show that smoking significantly increases the probability of developing OL (P = 0.02, OR = 8.33), a finding that agrees with Pentenero et al., 23 who affirmed that smoking is the most important aetiological factor in the development of potentially malignant disorders. Ho et al. 24 used Cox regression analysis to establish that smoking favours the appearance of leukoplakia but does not provoke its malignant transformation once it has appeared. Carrard et al. 25 studied a Brazilian population, noting that precancerous lesions were significantly more common among male subjects who smoked heavily; multivariable analysis showed that heavy smokers were 6.5- times more likely to develop precancerous lesions than non-smokers (95% CI = 2.0-20.1).
Lipids are a group of compounds known for their chemical properties and are sources of energy, acting as important cell constituents. They play a key role during cell growth division and in enzyme activity. Cholesterol and triglycerides are the most important cellular lipids and essential to diverse physiological functions. Cholesterol is important for maintaining the structure and functional integrity of all biological membranes and stabilizing DNA chains.
12-14 Lohe et al. 19 found no significant overall correlation between blood lipid profiles and smoking, in spite of the fact that blood lipid profiles and smoking show significant independent correlations with oral precancer and cancer.
Recent research indicates that quantitative changes in total lipid levels, cholesterol and HDL are significantly lower in cancer patients and patients with potentially malignant disorders. 16, 17, 26, 27, 28 Gavani et al. 14 compared cholesterol, triglyceride, HDL, LDL and very LDL between three groups: (i) healthy subjects (control group); (ii) patients with leukoplakia; and (iii) patients with squamous cell oral carcinoma. They found statistically significant differences in the reductions in levels of cholesterol in the carcinoma group in comparison with the control group, although no other significant differences were identified between groups and laboratory parameters. Meisel et al. 29 found that cholesterol and LDL levels were higher among patients with leukoplakia. Kumar et al. 26 claim that there may be an inverse relation between blood lipid profiles and squamous cell oral carcinoma. However, when potentially malignant disorders were investigated, no significant reduction in blood profile lipids was observed. The present results for blood lipid profiles obtained higher levels among leukoplakia patients with statistical significance for triglycerides and LDL. This could be due to the particularities of the sample; most leukoplakias in the study group were in the initial phases I and II so that, according to Kumar et al., 26 hypolipidemia could be a later change that takes place at the last moment during carcinogenesis, although its exact role as a mechanism of carcinogenesis has not yet been defined clearly.
High glucose levels in blood may lead to the excessive formation of free radicals, which could provoke carcinogenesis. [29] [30] [31] The present study found that glucose levels of over 100 mg/mL increased the risk of leukoplakia (P = 0.03, OR = 6.35). Dietrich et al. 5 have pointed out that for diabetic patients the risk of OL doubles. Findings by Albrecht et al. 31 tell us that the prevalence of OL among diabetic patients is 6.2% compared with 2.2% among control patients; it was also noted that precancerous lesions often occurred in the second year of established diabetes.
A recent meta-analysis by Gong et al. 30 of type 2 diabetes mellitus (DM) and risk for oral cancer and potentially malignant oral lesion indicated that type 2 DM poses a high risk of developing oral cancer or precancerous lesions in comparison with non-diabetic subjects, with type 2 DM exercising its main effect during the first stages of oral carcinogenesis. Maybe the oral medicine community should consider assessing systemic markers in patients with leukoplakia.
Several other risk factors associated with malignant transformation have been described: female gender, duration of the lesion, idiopathic leukoplakia (among non-smokers), localization (the tongue or mouth floor), a size of over 20 mm 2 , non-homogeneous clinical form, severe dysplasia the presence of multiple lesions. 8, 9 The presence of epithelial dysplasia is an important predictive factor for determining the potential malignancy of leukoplakia. 32 The present study found that the nonhomogeneous clinical form showed a significant effect on the risk of dysplasia (P = 0.039, OR = 9.06), as did smoking (P = 0.044, OR = 28.33). However, we should bear in mind that indications of malignant transformation should not limit themselves to these criteria, as the prognosis of any case is difficult due to the biological heterogeneity of these lesions. 3, 7, 9 The present study had some limitations, mainly due to the retrospective study design which required blood sample analysis of each case at a single moment; the study did not include any follow-up monitoring of biochemical profiles. The results need validation; further studies of leukoplakia patients with follow-up monitoring are necessary to gain a complete understanding of carcinogenesis.
CONCLUSIONS
Patients with altered blood lipid profiles, increases in glycemia, and smokers constitute groups at risk of developing OL, but further research is necessary to obtain epidemiological data and determine the mechanisms involved in the initial changes that take place during carcinogenesis.
